![Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/55a279b707f0cd71181a5efa8b3d3cd864555701-3002x1684.png?w=350&fit=crop&auto=format)
- Oncology NEWS International Vol 6 No 10
- Volume 6
- Issue 10
Public Health Groups Close Ranks Against Tobacco Industry
WASHINGTON-The Administration’s demand that Congress strengthen areas of the proposed tobacco agreement (see article above) won praise from a number of organizations that had criticized the initial settlement as too weak. “The opportunity to enact the right tobacco policy has never been greater,” said John R. Seffrin, PhD, chief executive officer of the American Cancer Society.
WASHINGTONThe Administrations demand that Congress strengthen areas of the proposed tobacco agreement (see article above) won praise from a number of organizations that had criticized the initial settlement as too weak. The opportunity to enact the right tobacco policy has never been greater, said John R. Seffrin, PhD, chief executive officer of the American Cancer Society.
The ACS has joined forces with 10 other major national public health organizations to garner grassroots support to help move the proposal through Congress quickly before momentum fades.
ASCOs Position
The American Society of Clinical Oncology (ASCO), in a statement issued a few days before the Presidents address, also called for major changes to strengthen the proposed settlement.
Of special concern is the focus of the $25 billion research fund included in the tobacco settlement. The Society wants to see the fund sponsor a balanced portfolio of basic and clinical research on tobacco-related cancers and other diseases, and install a rigorous, science-based, peer-reviewed system for making grants.
Articles in this issue
about 28 years ago
Toremifene, Tamoxifen Equivalent in Advanced Breast Cancerabout 28 years ago
Fluorescence ‘LIFE’ Images Spot Occult Lung Cancer Lesionsabout 28 years ago
The Issue That Won’t Go Away: Screening Mammographyabout 28 years ago
News in Brief...about 28 years ago
Concurrent Better Than Sequential Chemo-RT in NSCLCabout 28 years ago
Consumer Version of Merck & Co’s Famous Manual Is Availableabout 28 years ago
A Talk With Dr. Richard Klausner, Head of the NCIabout 28 years ago
Age Is a Factor in Survival of SqCC of the Head and Neckabout 28 years ago
Symptom-Based Staging of Head & Neck CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.